D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

Benzinga · 06/10 11:08
D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.